A federal grant puts MUSC in elite company, delivering health care through technology.
Researcher Jacqueline Kraveka is part of precision medicine trial to help children with neuroblastoma.
Dr. Chanita Hughes-Halbert is the Distinguished AT&T Endowed Chair in Cancer Equity at MUSC.
Dr. Raymond DuBois explains how national project likely to advance cancer research in exciting ways.
Chanita Hughes-Halbert, Ph.D.
SmartState Center of Economic Excellence AT&T Distinguised Endowed Chair in Cancer Equity, Professor of Psychiatry and Behavioral Sciences, and Associate Dean for Assessment and Evaluation
Dr. Raymond N. DuBois explains how national project likely to advance cancer research in exciting ways.
The numbers tell the scope of the project. There are 30 researchers collaborating across academic and corporate borders to roll out 10 Stand Up to Cancer (SU2C) Catalyst clinical trial projects that combine cancer treatments from nine different pharmaceutical companies.